Recently Viewed

News Announcement

Ajanta Pharma: Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

03-Jul-2026 Follow Value Research Online on Google download pdfDownload PDF Ajanta Pharma

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.